Poland· PL-100425268
Qsiva
A phentermine and topiramate product containing phenterminum + topiramatum, registered in Poland by Vivus BV. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Phentermine and topiramate is registered in 7 of 19 countries.
Countries holding a registration under ATC A08AA51 (phentermine and topiramate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Phentermine and topiramate · ATC A08AA51
7 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Phenterminum + Topiramatum
- Manufacturer
- Vivus BV
- Country
- Poland (PL)
- ATC code
- A08AA51
- ATC class
- Phentermine and topiramate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991468019
- gtin05909991468026
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Phentermine and topiramate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesphentermine and topiramatePrasco Laboratories
- CzechiaQSIVAVivus B.V., Amsterdam
- IrelandQsiva 11.25 mg/69 mg hard modified-release capsulesVivus B.V.
- SwedenQsiva 11,25 mg/69 mg Kapsel med modifierad frisättning, hårdVIVUS BV
- NorwayQsivaVIVUS BV
- FinlandQsivaVIVUS BV
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Czechia · Qsiva
- Denmark · Qsiva
- Finland · Qsiva
- Greece · Qsymia
- Croatia · Qsiva
- Hungary · Qsiva
- Ireland · Qsiva
- Iceland · Qsiva
- Lithuania · Qsiva
- Malta · Qsiva
- Norway · Qsiva
- Portugal · Qsiva
- Romania · Qsiva
- Sweden · Qsiva
- Slovenia · Qsiva
- Slovakia · Qsiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4a31e38-c7fd-4c9f-99b9-678233aec3a5 GET /v1/drugs/c4a31e38-c7fd-4c9f-99b9-678233aec3a5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki o zmodyfikowanym uwalnianiu, twarde",
"source": "urpl",
"strength": "3,75 mg + 23 mg",
"packaging": "05909991468019 ¦ Rpz ¦ 142234\n14 kaps.\n05909991468026 ¦ Rpz ¦ 142235\n30 kaps.",
"substance": "Phentermini hydrochloridum 4.67 mg + Topiramatum 23 mg",
"common_name": "Phenterminum + Topiramatum",
"pl_product_id": "100425268",
"pozwolenie_nr": "27275",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about phentermine and topiramate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.